In conditional HuR knockout mice (HurIKO), tumor burden is significantly reduced, with intestinal tumor numbers decreasing by approximately 60% and total tumor area decreasing by about 70% in CRC, alongside a notable reduction in tumor volume (116). This evidence concerns the gene ELAVL1 and colorectal carcinoma.